KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Tax Rate: 2015-2025

Historic Tax Rate for Supernus Pharmaceuticals (SUPN) over the last 8 years, with Sep 2025 value amounting to 22.15%.

  • Supernus Pharmaceuticals' Tax Rate rose 781.00% to 22.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.02%, marking a year-over-year decrease of 962.00%. This contributed to the annual value of 24.53% for FY2024, which is 2795.00% down from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Tax Rate stood at 22.15% for Q3 2025, which was down 46.90% from 41.71% recorded in Q4 2024.
  • In the past 5 years, Supernus Pharmaceuticals' Tax Rate registered a high of 95.17% during Q2 2023, and its lowest value of 14.34% during Q3 2024.
  • In the last 3 years, Supernus Pharmaceuticals' Tax Rate had a median value of 33.02% in 2024 and averaged 41.11%.
  • Its Tax Rate has fluctuated over the past 5 years, first soared by 6,426bps in 2023, then slumped by 7,084bps in 2024.
  • Supernus Pharmaceuticals' Tax Rate (Quarterly) stood at 25.55% in 2021, then skyrocketed by 687bps to 27.49% in 2022, then skyrocketed by 6,426bps to 95.17% in 2023, then slumped by 7,084bps to 41.71% in 2024, then spiked by 781bps to 22.15% in 2025.
  • Its Tax Rate was 22.15% in Q3 2025, compared to 41.71% in Q4 2024 and 14.34% in Q3 2024.